Cab4b:在严重新生儿血小板减少症中发现的第一个由糖蛋白IX携带的人类血小板抗原
一名39岁女性在三次流产后间隔一年分娩两名严重血小板减少新生儿(4×10^9/L和33×10^9/L)并伴颅内出血。血清学、基因组和体外研究鉴定出GPIX的c.368C>T变异导致Pro123Leu替换,该变异定义了一个新的同种抗原Cab4b,是首个描述于GPIX的人类血小板抗原。
要点
- 在两名严重新生儿血小板减少症患儿中鉴定出GPIX的c.368C>T变异,导致Pro123Leu替换,命名为Cab4b。
- 母亲为c.368C纯合,父亲和患儿为杂合,母亲血清与转染HEK293细胞中表达的Leu123型GPIX反应。
- c.368T等位基因(rs202229101)次要等位基因频率为0.0002,在120名法国受试者中未检测到。
核心结论
- NP_000165.1:p.Leu123等位基因命名为Cab4b,是首个描述于GPIX的血小板同种抗原。
- 在缺乏其他已知母胎不合的情况下,患儿1的病例提示抗Cab4b同种抗体可诱导严重血小板减少症。
研究设计与样本
- 对两例严重新生儿血小板减少症进行血清学、基因组和体外研究。
- 血清学研究采用单克隆抗体特异性血小板抗原固定术和流式细胞术。
- 人类血小板同种抗原(HPA)基因分型采用BioArray HPA BeadChip和PCR序列特异性引物技术。
- 基因组DNA通过PCR产物直接测序研究,突变糖蛋白在瞬染HEK293细胞中表达。
主要发现
- 患儿1和患儿2血小板计数分别为4×10^9/L和33×10^9/L,均伴颅内出血。
- MAIPA assay中,母亲血清与父亲和患儿1的血小板GPIbIX微弱反应,不与母亲或面板血小板反应。
- 除患儿2的HPA-1b外,22个已知HPA系统中未发现母胎不合。
- 基因组测序揭示父亲GPIX变异(NM_000174.4:c.368C>T),父亲和患儿为杂合,母亲为c.368C纯合。
- 母亲血清与转染HEK293细胞中与GPIb共表达的GPIX NP_000165.1:p.Leu123形式反应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Essentials Life-threatening maternofetal thrombocytopenias mostly depend on αIIb β3 antigens. We performed serological, genomic and in vitro studies of two life-threatening thrombocytopenias. Identification of a c.368C>T variation leading to Pro123Leu substitution in GPIX. A rare GPIX variant reported in a genomic database define a new alloantigen. SUMMARY: Background After three miscarriages, a 39-year-old woman gave birth, with a 1-year interval, to two severely thrombocytopenic neonates (4 ×109 L-1 and 33 ×109 L-1 ) with intracranial hemorrhages. Transfusion of platelet concentrates corrected the thrombocytopenia. The outcome was favorable for the first child, but the second one died 10 days after cesarean delivery (31 weeks of gestation + 6 days). Methods Serologic studies were performed with mAb-specific immobilization of platelet antigens and flow cytometry techniques. Human platelet alloantigen (HPA) genotyping was performed with the BioArray HPA BeadChip and PCR-sequence-specific primer techniques. Genomic DNA was studied by direct sequencing of PCR products. The mutant glycoprotein (GP) was expressed in transiently transfected HEK293 cells. Results In MAIPA assay, the maternal serum faintly reacted with GPIbIX from paternal and child 1 platelets, but not with maternal or panel platelets. No maternofetal incompatibility was found in the 22 known HPA systems, tested except for HPA-1b in child 2. A new alloantigen carried by GPIbIX was suspected. Genomic sequencing revealed a paternal GPIX variation (NM_000174.4:c.368C>T). The father and children were heterozygous and incompatible with the mother, who was NM_000174.4:c.368C homozygous. The maternal serum reacted with the GPIX NP_000165.1:p.Leu123 form coexpressed with GPIb in transfected HEK293 cells. The NM_000174.4:c.368T allele (rs202229101) has a minor allele frequency of 0.0002, and was not detected in 120 French subjects (families with fetal and neonatal alloimmune thrombocytopenia [FNAIT]), suggesting that it is rarely implicated in alloimmunization. Conclusion The NP_000165.1:p.Leu123 allele named Cab4b is the first platelet alloantigen described on GPIX. In the absence of other known maternofetal incompatibility, the child 1 case suggests that anti-Cab4b alloantibodies can induce severe thrombocytopenias.
引用
- Jallu V, Beranger T, Bianchi F, et al. Cab4b, the first human platelet antigen carried by glycoprotein IX discovered in a context of severe neonatal thrombocytopenia. J Thromb Haemost. 2017. PMID: 28561420. doi:10.1111/jth.13744
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。